INDICAID COVID-19 Rapid Antigen Test: Fast and Accurate COVID-19 Detection
ProcurenetShort description
INDICAID COVID-19 Rapid Antigen Test
- Speedy Outcomes: Offers test results in just 20 minutes
- Precision: Demonstrates 96% sensitivity and 99% specificity, clinically attested
- User-friendly: Requires no equipment or special setup, promoting an effortless process
- Worldwide Approval: Given the green light for emergency use by US FDA EUA and EU CE mark
- Multiple Variant Identification: Recognizes multiple COVID-19 strains including Alpha, Beta, Epsilon, Delta, Zeta, and Omicron
- Top Quality: Formulated in Hong Kong, renowned for assurance in product quality
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Advanced Detection Capabilities with INDICAID COVID-19 Rapid Antigen Test
The COVID-19 pandemic has brought about the serious necessity of quick and precise testing methods. The INDICAID COVID-19 Rapid Antigen Test stands as a beacon in this regard, offering efficient and highly accurate detection of SARS-CoV-2 antigens. This advanced diagnostic tool operates via nasal swab samples, devoid of the need for elaborate equipment or complex facilities.
High-Speed Results
With this exceptional antigen test, you can obtain definitive results within 20 minutes. This ultra-fast testing process is conducive for immediate diagnosis and treatment, ultimately checking the spread of the virus.
Exceptional Accuracy
The INDICAID COVID-19 Antigen Test prides itself in its accuracy, with clinical validation displaying an impressive 96% sensitivity and 99% specificity. This robust performance ensures early recognition of positive cases, vital for isolating and treating the patients involved.
Simple Operation
This CE-marked lateral flow immunoassay can be seamlessly operated by both professional healthcare providers and home users. It is independent of complex facilities, thus being convenient and accessible for all.
International Recognition
The INDICAID COVID-19 Rapid Antigen Test is the first product from Greater China to be granted emergency use authorization by the US FDA. Furthermore, it possesses the EU CE mark recognition, validating the product's quality and reliability on a global scale.
Wide Detection Threshold
Significantly, this COVID-19 Antigen Test has proven capabilities for detecting the Alpha, Beta, Epsilon, Delta, Zeta, and Omicron variants. This broad detection threshold is an invaluable asset in the global fight against the pandemic, given the continuous evolution of the virus.
Simple Testing Procedure
The testing process involves an initial nasal swab sample from the patient, which is then mixed with the provided buffer solution. On transferring this solution into the sample well of the test kit, results can be interpreted within a span of 20 to 25 minutes.
